Search research articles
Contact Us
Filters
Showing results (351-360 of 470) with videos related to
Page
of 47
Sort By:
Nature Communications
|
February 8, 2023
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer
Lingzhi Hong, Muhammad Aminu, Shenduo Li, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 4, 2026
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder
Joao Vitor Mahler, Gerome B Vallejos, Takahisa Mikami, et al.
Cell Reports. Medicine
|
March 12, 2024
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept
Morteza Salehjahromi, Tatiana V Karpinets, Sheeba J Sujit, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 23, 2020
Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLC
Pierre-Olivier Gaudreau, Marcelo V Negrao, Kyle G Mitchell, et al.
Journal for Immunotherapy of Cancer
|
August 11, 2021
Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer
Marcelo V Negrao, Ferdinandos Skoulidis, Meagan Montesion, et al.
Science Translational Medicine
|
January 24, 2020
PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma
Xiaochao Tan, Priyam Banerjee, Edward A Pham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 15, 2021
Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer
L Federico, D J McGrail, S-E Bentebibel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2025
The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study
M M Zheng, Y Xia, K Pan, et al.
Nature Communications
|
July 24, 2025
Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC
Maliazurina B Saad, Qasem Al-Tashi, Lingzhi Hong, et al.
Cancer Discovery
|
July 18, 2018
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade
Limo Chen, Lixia Diao, Yongbin Yang, et al.
Page
of 47
Search research articles
Search
Showing results (351-360 of 470) with videos related to
Sort By:
Page
of 47
Nature Communications
|
February 8, 2023
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer
Lingzhi Hong, Muhammad Aminu, Shenduo Li, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 4, 2026
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder
Joao Vitor Mahler, Gerome B Vallejos, Takahisa Mikami, et al.
Cell Reports. Medicine
|
March 12, 2024
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept
Morteza Salehjahromi, Tatiana V Karpinets, Sheeba J Sujit, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 23, 2020
Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLC
Pierre-Olivier Gaudreau, Marcelo V Negrao, Kyle G Mitchell, et al.
Journal for Immunotherapy of Cancer
|
August 11, 2021
Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer
Marcelo V Negrao, Ferdinandos Skoulidis, Meagan Montesion, et al.
Science Translational Medicine
|
January 24, 2020
PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma
Xiaochao Tan, Priyam Banerjee, Edward A Pham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 15, 2021
Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer
L Federico, D J McGrail, S-E Bentebibel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2025
The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study
M M Zheng, Y Xia, K Pan, et al.
Nature Communications
|
July 24, 2025
Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC
Maliazurina B Saad, Qasem Al-Tashi, Lingzhi Hong, et al.
Cancer Discovery
|
July 18, 2018
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade
Limo Chen, Lixia Diao, Yongbin Yang, et al.
Page
of 47